Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030Ramat Gan, Israel, Feb. 18, 2025 (GLOBE ...

The U.S. market for liver cirrhosis treatment is projected to grow to approximately $15 billion by 2030. Namodenoson is a small orally bioavailable drug that binds with high affinity and ...

Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

The U.S. market for liver cirrhosis treatment is projected to grow to approximately $15 billion by 2030.

After a while, your liver may not be able to work well or at all. It's important to know the cause of your cirrhosis so you can get the right treatment and keep it from getting worse. The most ...

an advanced stage of cirrhosis often associated with liver failure, currently has no approved therapeutic options other than liver transplantation. At 20 months into treatment, the patient reports ...

Goa Medical College sees alarming numbers of chronic liver disease admissions and deaths, with an increase in younger ...

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

Veteran Actor Uttam Mohanty in Critical Condition, Flown to Delhi for Liver Cirrhosis Treatment. Read on to know more.